InMed Pharmaceuticals Inc. (INM) Financials

$2.65

$0.02 (0.76%)
Last update: 04:00 PM EST
Day's range
$2.56
Day's range
$2.7
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420240%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%Profit Margin
Profit Margin
Revenue
Earnings

INM Income statement / Annual

Last year (2024), InMed Pharmaceuticals Inc.'s total revenue was $6.29 M, an increase of 14.77% from the previous year. In 2024, InMed Pharmaceuticals Inc.'s net income was -$10.50 M. See InMed Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $6.29 M $5.48 M $1.40 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $4.78 M $3.62 M $702.87 K $197.03 K $183.09 K $93.94 K $92.78 K $0.00 $0.00 $0.00
Gross Profit $1.51 M $1.86 M $699.85 K -$197.03 K -$183.09 K -$93.94 K -$92.78 K $0.00 $0.00 $0.00
Gross Profit Ratio 0.24 0.34 0.5 0 0 0 0 0 0 0
Research and Development Expenses $5.15 M $4.94 M $9.38 M $5.34 M $5.20 M $4.30 M $1.52 M $573.72 K $292.84 K $759.85 K
General & Administrative Expenses $7.18 M $7.75 M $8.84 M $4.48 M $3.50 M $6.00 M $0.00 $2.79 M $1.48 M $2.62 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.18 M $7.75 M $8.84 M $4.48 M $3.50 M $6.00 M $5.17 M $2.79 M $1.48 M $2.62 M
Other Expenses $300.33 K $267.93 K $239.05 K $120.87 K $161.97 K $94.72 K -$0.00 $75.22 K $67.41 K $75.76 K
Operating Expenses $12.63 M $12.96 M $18.46 M $9.94 M $8.87 M $10.39 M $6.69 M $3.44 M $1.84 M $3.46 M
Cost And Expenses $17.41 M $16.58 M $19.16 M $9.94 M $8.87 M $10.39 M $6.78 M $3.44 M $1.84 M $3.46 M
Interest Income $721.97 K $652.37 K $123.72 K $16.02 K $125.89 K $330.44 K $69.55 K $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $360.35 K $18.62 K $0.00 $0.00 $495.17 $47.92 $3.53 K
Depreciation & Amortization $826.76 K $789.55 K $658.96 K $197.03 K $183.09 K $94.72 K $89.60 K $75.22 K $67.41 K $75.76 K
EBITDA -$10.30 M -$10.31 M -$17.10 M -$9.80 M -$8.58 M -$10.26 M -$6.69 M -$3.36 M -$1.77 M -$3.38 M
EBITDA Ratio -1.64 -1.88 -12.19 0 0 0 0 0 0 0
Operating Income Ratio -1.77 -2.03 -12.66 0 0 0 0 0 0 0
Total Other Income/Expenses Net $637.29 K $588.55 K -$6.19 M $2.12 M $60.73 K $262.10 K $69.77 K -$495.17 -$47.92 -$3.53 K
Income Before Tax -$10.49 M -$10.51 M -$23.95 M -$10.20 M -$8.68 M -$10.10 M -$6.71 M -$3.44 M -$1.84 M -$3.46 M
Income Before Tax Ratio -1.67 -1.92 -17.07 0 0 0 0 0 0 0
Income Tax Expense $9.71 K $17.35 K $0.00 $360.35 K $18.62 K -$262.10 K $0.00 $495.17 $47.92 $3.53 K
Net Income -$10.50 M -$10.53 M -$23.95 M -$10.20 M -$8.94 M -$10.01 M -$6.71 M -$3.44 M -$1.84 M -$3.46 M
Net Income Ratio -1.67 -1.92 -17.07 0 0 0 0 0 0 0
EPS -10.071 -43 -426.9 -470.6 -581.1 -640.1 -493.5 -412.6 -325.8 -768.3
EPS Diluted -10.071 -43.1 -427 -470.6 -581.1 -640.1 -493.5 -412.6 -325.8 -768.3
Weighted Average Shares Out $762.11 K $244.54 K $56.08 K $26.88 K $20.88 K $20.71 K $17.27 K $10.84 K $7.30 K $5.59 K
Weighted Average Shares Out Diluted $762.11 K $244.85 K $56.08 K $26.88 K $20.88 K $20.71 K $17.27 K $10.84 K $7.30 K $5.59 K
Link